use of Aloevera in liver disease
Phase 4
- Conditions
- Health Condition 1: null- liver disease
- Registration Number
- CTRI/2011/12/002284
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
patients attending medicine out patient and inpatient department at SVBP hospital,L.L.R.M medical college meerut having liver disease were taken and randomly divided in two groups.
Exclusion Criteria
age less than 15yr or more than 60 yr.
congenital liver disease
pregnant and lactating female
chronic decompensated liver disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SGPT <br/ ><br>SGOT <br/ ><br>serum bilirubin <br/ ><br>serum alkaline phosphataseTimepoint: initially <br/ ><br>after 2 weeks <br/ ><br>after 4 weeks <br/ ><br>after 6 weeks <br/ ><br>after 8 weeks
- Secondary Outcome Measures
Name Time Method ATimepoint: NA